Bharat Biotech's Covaxin gets a nod for emergency use in children aged 6-12 years

DCGI has also approved Zayed Cadila's Zycov D vaccine for emergency use for children above 12 years of age.

Bharat Biotechs Covaxin,  emergency use for children, 6 12 years, Subject Expert Committee, Drug Controller General of India, Corbevax, India News- True Scoop
The Drug Controller General of India DCGI has approved Bharat Biotech's Covaxin for emergency use for children aged 6-12 years. Apart from this, DCGI has also approved Zayed Cadila's Zycov D vaccine for emergency use for children above 12 years of age.
 
The decision comes after a meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI), in which data was sought from Bharat Biotech for administering the COVID-19 vaccine Covaxin to children in the age group of 2-12 years.


The development comes just days after an expert panel of India's central drug authority recommended granting emergency use authorization for Biological E's COVID-19 vaccine Corbevax for children in the five to 11 years age group with certain conditions. 


Trending